spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

spot_img

sitefansalaran International News

Cupping, leeching and other ancient healing methods welcomed in Turkish hospitals

In a brightly lit treatment room at a private hospital in Istanbul, doctor Erdal Dilekci makes dozens of small, quick incisions on a patient's back as part of a centuries-old therapy known as wet cupping. The patient, 26-year-old nurse Furkan Ali Sayan, lies quietly as the doctor then places eight suction cups designed to draw out toxins and ease his neck and back pain. "I don't feel much yet, but I expect the benefits to come in the next few days," said Furkan, having his first session. Known in Turkey as hacamat, wet cupping and other traditional treatments such as leech therapy are increasingly moving to mainstream clinics as a complement to modern medicine and away from informal settings where infection risks are higher. Encouraged by legislative changes a decade ago, now 66 of Turkey's 81 provinces have certified medical doctors performing traditional methods in hospitals, the health ministry says. Dilekci, a specialist in physical medicine and rehabilitation, is among the hundreds of Turkish physicians integrating traditional and complementary medicine. "We use around 15 different methods, including ozone therapy, prolotherapy, acupuncture, and leech therapy," he said at the Medicana International Hospital. "They are regulated by the Health Ministry and taught under official certification programmes." He emphasised that...

Veterinary Pain Management Drugs Market: $3Billion by 2031, CAGR 4.8% Driven by Rising Pet Health Awareness

The veterinary pain management drugs market has become one of the fastest-evolving segments within the animal healthcare industry, driven by rising awareness of animal welfare, increased pet ownership, and greater spending on veterinary care. Pain management is a critical element of veterinary medicine because untreated pain negatively impacts animal health, slows recovery, and reduces overall well-being. From post-operative care to chronic disease management, veterinary analgesics have become essential to improving both companion animal and livestock health outcomes. According to DataM Intelligence, the Global Veterinary Pain Management Drugs Market reached US$ 2.06 billion in 2023 and is expected to reach US$ 3.00 billion by 2031, growing at a CAGR of 4.8% during the forecast period (2024–2031). This robust growth is fueled by the rising incidence of chronic conditions such as arthritis and cancer in pets, alongside greater demand for advanced veterinary treatments. North America leads the global market, thanks to high veterinary expenditure, advanced healthcare infrastructure, and strong pet ownership trends. Among product categories, NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) dominate due to their widespread use in managing pain and inflammation in animals.

Trump calls on pharmaceutical companies to justify success of COVID drugs

U.S. President Donald Trump on Monday called on pharmaceutical companies to justify the success of their drugs intended to treat COVID. He said there is disagreement on whether the drugs saved lives. "With CDC being ripped apart over this question, I want the answer, and I want it NOW," Trump wrote on Truth Social. "I have been shown information from Pfizer, and others, that is extraordinary, but they never seem to show those results to the public."

Senator Sanders says U.S. Health Secretary Kennedy must resign

U.S. Senator Bernie Sanders on Saturday called on Secretary of Health and Human Services Robert F. Kennedy Jr. to resign, days after a senior public health official was fired and four others resigned in disputes over Kennedy's unorthodox opposition to vaccines. Sanders, an independent senator from Vermont who caucuses with Democrats, wrote in a New York Times guest essay, opens new tab that Kennedy is "endangering the health of the American people now and into the future." This week, Kennedy ousted the director of the Centers for Disease Control and Prevention, Susan Monarez, less than a month into her tenure, deepening disarray at the nation's main public health agency. Monarez had refused to adopt new limitations on the availability of some vaccines urged by Kennedy, saying they went against scientific evidence. Four other senior CDC officials resigned in protest, citing anti-vaccine policies and misinformation promoted by Kennedy and his team; hundreds of their colleagues walked out of the CDC's headquarters in Atlanta in support of the departing leaders. Sanders, the ranking member of the Senate's health committee and an opponent of Kennedy's confirmation earlier this year, wrote that Kennedy ousted Monarez because she refused "to act as a rubber stamp for his dangerous...

MS Pharma establishes first MENA biologics manufacturing centre in Saudi Arabia

MS Pharma has officially opened the first biologics manufacturing plant in the Middle East, strategically located in Saudi Arabia. The plant has received Good Manufacturing Practices (GMP) approval from the Saudi Food and Drug Authority (SFDA), establishing a hub for advanced biopharmaceutical production in the Middle East and North Africa (MENA) region. With formulation, filling and finishing, and freeze-drying capabilities, this $50 million investment positions MS Pharma as the region's leading biologics company. It also positions the company as a trusted partner for global pharmaceutical companies seeking to access the Saudi Arabian market and the MENA region through local and contract manufacturing solutions for broader international markets. The factory is designed to meet the highest international regulatory standards, including the US EMA and FDA, and specialises in monoclonal antibodies and complex peptides, two of the world's most in-demand classes of biologic treatments. The plant also has the region's first in-house bioanalytical testing laboratories, eliminating the need for overseas testing services and accelerating time to market for critical treatments.

Kennedy names his deputy Jim O’Neill as interim US CDC chief after Monarez firing

U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. has named his deputy, Jim O'Neill, as acting director at the Centers for Disease Control and Prevention after ousting the former director less than a month into her tenure. President Donald Trumpfired on Wednesday CDC Director Susan Monarez after she resisted changes to vaccine policy advanced by Kennedy that she believed contradicted scientific evidence, further destabilizing the already embattled agency. "Together, we will rebuild this institution into what it was always meant to be: a guardian of America's health and security," Kennedy wrote on Thursday in a memo to CDC staff seen by Reuters. "To help advance this mission, I am pleased to announce that Deputy Secretary of Health and Human Services Jim O'Neill is now also serving as Acting Director of the CDC." Monarez's firing triggered the resignations of four senior CDC officials who cited anti-vaccine policies and misinformation pushed by Kennedy and his team. The CDC has faced mounting challenges under Kennedy's leadership, including a shooting at its Atlanta headquarters earlier this month. The union representing CDC workers said the incident "compounds months of mistreatment, neglect, and vilification that CDC staff have endured." The White House sought to cut the agency's...

Cancer Drugs Market Size & Share | Industry Report, 2034

Explore the Cancer Drugs Market with research insights on growth trends, key therapies, innovations, and future opportunities. Gain a competitive edge with our latest in-depth study of the Global Cancer Drugs Market. This research provides strategic insights into market dynamics, competitive intensity, and key developments that are shaping the industry’s future. Our latest report delivers a detailed evaluation of global Cancer Drugs industry trends, designed for business leaders, investors, consultants, and decision-makers. The study includes current market size, growth forecasts, pricing trends, product innovations, and regional demand shifts By leveraging real-time market statistics, the report enables better forecasting, risk assessment, and strategic planning. It covers: • Key growth drivers and challenges • Capacity expansions and technology advancements • Evolving competitive landscape • Strategic shifts in supply chains and pricing Our market experts have analyzed historical and current data to help stakeholders decode evolving patterns, identify high-growth segments, and make informed investment or business decisions. ________________________________________ Cancer Drugs Market Size & Forecast As of 2025, the market was valued at USD $238.4 Billion, with projections suggesting a steady rise to USD $688.1 Billion by 2034, expanding at a CAGR of 12.5% during the forecast period (2025–2034).

US CDC chief fired after weeks in role, challenges ouster as four top officials resign

U.S. Centers for Disease Control and Prevention Director Susan Monarez has been fired, the White House said on Wednesday, less than a month after being sworn in, and four senior officials have resigned amid growing tensions over vaccine policies and public health directives. Secretary of Health and Human Services Robert F. Kennedy Jr. has made sweeping changes to vaccine policies, including withdrawing federal recommendations for COVID shots for pregnant women and healthy children in May, and firing all members of the CDC's expert vaccine advisory panel in June whom he replaced with hand-picked advisers including fellow anti-vaccine activists. One of the officials that quit said the CDC's vaccination recommendations were putting young Americans and pregnant women at risk. White House spokesman Kush Desai late on Wednesday said Monarez was not "aligned with the President's agenda of Making America Healthy Again". Since she had "refused to resign despite informing HHS leadership of her intent to do so, the White House has terminated Monarez from her position with the CDC," Desai said. Monarez's attorneys, Mark S. Zaid and Abbe David Lowell, denied she had resigned or had been fired, adding in a statement that "as a person of integrity and devoted to science, she will not...

China screened 600 million for disease, keeping up COVID-era controls

Chinese customs screened 600 million people at international ports for infectious diseases over the past five years, officials said on Monday, while pledging to refine containment protocols that became a hallmark of Beijing's zero-COVID policy. Customs officials detected more than 180,000 cases of infectious disease at China's borders during that time, Zhao Zenglian, deputy director general of the customs agency, told a news conference on border management. Australia and Britain both warn travellers of possible medical checks upon arrival in China, even as Beijing seeks to revive inbound tourism and attract foreign investment to give its struggling economy a boost. "Over 600 million inbound travellers and 300 million inbound vehicles and vessels were screened, and 5.25 million disease vectors were intercepted, effectively preventing the entry of over 30 types of vector-borne diseases," Zhao said. He did not specify which diseases officials were screening for but since the pandemic China has warned of the risks posed by imported cases of mosquito-borne virus chikungunya and Mpox, a viral infection marked by flu-like symptoms and pus-filled lesions. "Quarantine defences at ports of entry have become more robust... Health and disease control departments have coordinated to build a 'closed-loop' management system: from overseas, to the border, and then...

Study Finds Widespread Gaps in Knowledge About HPV and Its Link to Cancer

•HPV affects 43 million people annually, with high-risk types causing cervical, vulvar, vaginal, penile, anal, and oropharyngeal cancers. •Only one-third of Americans are aware of HPV's cancer links, with significant knowledge gaps in Midwestern and Southern states. Despite the widespread prevalence of human papillomavirus (HPV) in the United States, only 1 in 3 adults are aware that it can cause 6 types of cancer, according to an analysis from researchers at MUSC Hollings Cancer Center. The findings come amid rising cases of HPV-related cancers and a climate of vaccine skepticism. HPV is the most common sexually transmitted infection in the country, affecting approximately 43 million people each year—many of whom are unaware they are infected. Most cases are short-lived and are cleared by the immune system, but persistent infection with high-risk HPV types can lead to cellular changes that develop into cancer. There are more than 200 types of HPV viruses, classified by whether they infect skin (cutaneous) or mucosal cells, as well as by their associated cancer risk. Low-risk types, including HPV 6 and 11, are linked to warts on the hands and feet, respiratory and laryngeal papillomas, low-grade abnormalities of mucosal cells, and genital warts. High-risk types, such as HPV 16...